Brivaracetam
Medication used to treat seizures
Brivaracetam
Brivaracetam, sold under the brand name Briviact among others, is a chemical analog of levetiracetam, a racetam derivative with anticonvulsant (antiepileptic) properties. It has been approved since 2016. It is marketed by the pharmaceutical company UCB. It is used to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs.
Read on Wikipedia · Image Harbin, Public domain
Open boosters, collect cards and trade them. Free to play.
Play for free